JBL
Jabil Inc.
September 30, 2026 · pre-market
- Rarity
- 1.17
- Peak move
- −5.65%
- Float cap
- $33.4B
Jabil provides engineering, manufacturing, and supply chain solutions, including design, production, and product management services across the product lifecycle. It serves companies in regulated industries, intelligent infrastructure, and connected living and digital commerce, spanning automotive, healthcare, packaging, renewables, AI infrastructure, networking, and warehouse automation. Operations are worldwide, with facilities in China, Malaysia, Mexico, and the United States.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
8 events · 2 from SEC or newswire · 2 timed with the move- Key eventTimed with the move
earnings_releaseJabil reported fiscal Q4 2026 results for the quarter ended August 31, 2026, with net revenue of $10.616 billion, up 28.6% year over year, GAAP diluted EPS of $3.76, core EPS of $4.40, and net income of $398 million; full fiscal 2026 revenue was $36.0 billion with GAAP diluted EPS of $9.75.
- Key eventTimed with the move
guidance_changeJabil guided fiscal 2027 revenue to $44.5 billion, core operating margin to 6.1%, core diluted EPS to $17.55 and adjusted free cash flow to about $1.6 billion, and guided Q1 fiscal 2027 revenue to $10.6-$11.4 billion with core EPS of $3.80-$4.20.
major_contractJabil holds an authorized AI infrastructure purchase agreement with Akamai Technologies covering large-scale AI data center equipment.
- Key event
buybackJabil announced a $1.5 billion share buyback plan.
index_rebalanceJabil was added to the FTSE All-World Index (USD) in September 2026.
investor_dayJabil held its annual investor briefing alongside its fiscal Q4 2026 results call on September 30, 2026, outlining fiscal 2027 priorities including AI-related revenue growth, margin expansion above 6%, and adjusted free cash flow of approximately $1.6 billion.
analyst_ratingBofA Securities raised its price target on Jabil to $475 from $470 and reiterated a Buy rating on September 24, 2026, ahead of Jabil's fiscal Q4 results and investor day on September 30, citing strong AI/datacenter revenue and FY2027 free cash flow above $1.5 billion.
regulatory_actionThe FDA's Center for Drug Evaluation and Research issued a warning letter to Jabil Inc. citing significant CGMP violations at its Pharmaceutics International Inc. sterile injectables facility in Cockeysville, Maryland.